Simulations Plus, Inc. (SLP) Stock Analysis
DELISTED
What happened to Simulations Plus, Inc. (SLP) stock?
Simulations Plus, Inc. (SLP) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 45.14 means the share price is 45.14 times one year of earnings per share. Market cap $374M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Simulations Plus, Inc. (SLP). Simulations Plus, Inc. develops and sells software for drug discovery and development, leveraging AI and machine learning. Their products simulate molecular properties and predict drug interactions for pharmaceutical, biotech, and related industries.
Last analyzed: Jun 1, 2026Simulations Plus, Inc. (SLP) Technology Profile & Competitive Position
More about this archive record
Can I still buy SLP shares?
No. SLP stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for SLP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SLP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Simulations Plus, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.